Tower Research Capital (TRC)’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Tower Research Capital (TRC)’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,318	Closed	-$43K	–	4538
2017 Q3	$43K	Sell	2,318 -113	-5%	-$1.96K	﹤0.01%	2111
2017 Q2	$40K	Buy	2,431 +2,216	+1,031%	+$30.8K	﹤0.01%	865
2017 Q1	$3K	Sell	215 -750	-78%	-$12K	﹤0.01%	2555
2016 Q4	$18K	Buy	965 +367	+61%	+$7.04K	﹤0.01%	2265
2016 Q3	$13K	Buy	+598	New	+$11.2K	﹤0.01%	1904
2016 Q2	–	Hold	0	–	–	–	5381
2016 Q1	–	Sell	-218	Closed	-$4K	–	5466
2015 Q4	$4K	Sell	218 -448	-67%	-$7.61K	﹤0.01%	3334
2015 Q3	$12K	Buy	+666	New	+$14.8K	﹤0.01%	2194
2015 Q2	–	Sell	-2,859	Closed	-$63K	–	5459
2015 Q1	$63K	Buy	+2,859	New	+$61.7K	0.01%	1282

Other funds holding ENTL

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Sand Grove Capital Management London, United Kingdom $428M AUM 131.11% 1-Year Est. Return

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return